Table 5.
DXA Z-scores of children
Years following initiation of imiglucerase | Baseline DXA ≤−1 (n=22 patients, 80 assessments) |
||
---|---|---|---|
Predicted DXA Z-score | Lower 95% confidence interval | Upper 95% confidence interval | |
Baseline (−1 to<0) | −1.38 | −1.73 | −1.03 |
0 to<1 | −1.31 | −1.63 | −0.98 |
1 to <2 | −1.24 | −1.54 | −0.93 |
2 to <3 | −1.14 | −1.45 | −0.83 |
3 to <4 | −1.03 | −1.37 | −0.69 |
4 to <5 | −0.92 | −1.31 | −0.54 |
5 to <6 | −0.88 | −1.29 | −0.47 |
6 to <7 | −0.73 | −1.25 | −0.21 |
7 to <8 | . | . | . |
8 to <9 | −0.55 | −1.26 | 0.16 |
9 to <10 | . | . | . |
DXA Z-scores of patients with 2 or more measurements from a non-linear mixed model in children (ages≥5 years to <12 years).